≡

Multiplex Assay Kit for Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay)

COL4-A1; Arresten; Collagen Alpha-1(IV)chain

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-102 98
EDTA plasma(n=5) 88-101 96
heparin plasma(n=5) 82-104 97
sodium citrate plasma(n=5) 82-93 89

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-96% 96-103% 86-94% 91-101%
EDTA plasma(n=5) 86-98% 94-101% 91-101% 98-105%
heparin plasma(n=5) 87-95% 78-96% 83-101% 84-104%
sodium citrate plasma(n=5) 98-105% 97-104% 78-99% 78-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:COL4a1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Research Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix–Directed Spheroid Formation Pubmed:26744523
PLoS One miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes 10.1371
Journal of Diabetes & Metabolic Disorders Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes
Experimental and Molecular Pathology  Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease Pubmed: 30817909
Journal of Diabetes & Metabolic Disorders In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes
Frontiers in Endocrinology Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes Pubmed: 31920992
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA149Mu01 Recombinant Collagen Type IV Alpha 1 (COL4a1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA149Mu02 Recombinant Collagen Type IV Alpha 1 (COL4a1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA149Mu01 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1) WB; IHC; ICC; IP.
PAA149Mu02 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1) WB; IHC; ICC; IP.
SEA149Mu ELISA Kit for Collagen Type IV Alpha 1 (COL4a1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA149Mu Multiplex Assay Kit for Collagen Type IV Alpha 1 (COL4a1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.